CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of PEN 323.22 billion. The enterprise value is 561.24 billion.

Market Cap	323.22B
Enterprise Value	561.24B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Oct 23, 2025

Share Statistics

Current Share Class	1.27B
Shares Outstanding	n/a
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.71%
Float	1.27B

Valuation Ratios

The trailing PE ratio is 198.77 and the forward PE ratio is 10.85.

PE Ratio	198.77
Forward PE	10.85
PS Ratio	0.24
PB Ratio	1.28
P/TBV Ratio	n/a
P/FCF Ratio	14.81
P/OCF Ratio	10.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.42, with an EV/FCF ratio of 25.72.

EV / Earnings	345.15
EV / Sales	0.43
EV / EBITDA	9.42
EV / EBIT	16.43
EV / FCF	25.72

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.12.

Current Ratio	0.83
Quick Ratio	0.59
Debt / Equity	1.12
Debt / EBITDA	4.62
Debt / FCF	12.99
Interest Coverage	3.28

Financial Efficiency

Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 4.06%.

Return on Equity (ROE)	0.58%
Return on Assets (ROA)	2.50%
Return on Invested Capital (ROIC)	4.06%
Return on Capital Employed (ROCE)	6.24%
Revenue Per Employee	5.23M
Profits Per Employee	6,266
Employee Count	300,000
Asset Turnover	1.54
Inventory Turnover	18.54

Taxes

In the past 12 months, CVS Health has paid 8.60 billion in taxes.

Income Tax	8.60B
Effective Tax Rate	85.28%

Stock Price Statistics

The stock price has increased by +25.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+25.63%
50-Day Moving Average	78.25
200-Day Moving Average	70.08
Relative Strength Index (RSI)	17.31
Average Volume (20 Days)	18

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, CVS Health had revenue of PEN 1.36 trillion and earned 1.63 billion in profits. Earnings per share was 1.29.

Revenue	1.36T
Gross Profit	181.33B
Operating Income	35.18B
Pretax Income	10.08B
Net Income	1.63B
EBITDA	51.15B
EBIT	35.18B
Earnings Per Share (EPS)	1.29

Full Income Statement

Balance Sheet

The company has 38.94 billion in cash and 283.44 billion in debt, giving a net cash position of -244.50 billion.

Cash & Cash Equivalents	38.94B
Total Debt	283.44B
Net Cash	-244.50B
Net Cash Per Share	n/a
Equity (Book Value)	253.48B
Book Value Per Share	199.09
Working Capital	-54.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 31.58 billion and capital expenditures -9.76 billion, giving a free cash flow of 21.82 billion.

Operating Cash Flow	31.58B
Capital Expenditures	-9.76B
Free Cash Flow	21.82B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.35%, with operating and profit margins of 2.59% and 0.12%.

Gross Margin	13.35%
Operating Margin	2.59%
Pretax Margin	0.74%
Profit Margin	0.12%
EBITDA Margin	3.77%
EBIT Margin	2.59%
FCF Margin	1.61%

Dividends & Yields

This stock pays an annual dividend of 9.55, which amounts to a dividend yield of 12.73%.

Dividend Per Share	9.55
Dividend Yield	12.73%
Dividend Growth (YoY)	-3.92%
Years of Dividend Growth	5
Payout Ratio	722.81%
Buyback Yield	0.37%
Shareholder Yield	13.10%
Earnings Yield	0.50%
FCF Yield	6.75%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.18
Piotroski F-Score	6